Company profile · Cham, Switzerland

4D Lifetec AG

Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics · Diagnostic platform commercialization

Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.

Lead
Giancarlo Rizzoli (verified ↗)
Address
Cham, Zug, Switzerland (source ↗)
Compliance
CE-IVD certified 4D Lifetest applications
Last reviewed
24 Apr 2026 (1mo ago)
Scale
Diagnostic platform commercialization
Capabilities
4D-Comet Blood-Test Technology · CE-IVD Cancer Diagnostics · High-Throughput Sample Processing
Founded
2014
Headcount
11-50
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Giancarlo Rizzoli

Chief Executive Officer

Check official leadership source
Full addressCham, Zug, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

Startupticker coverage placing 4D Lifetec in Cham, Zug.

Open source
Operating profile

Diagnostic platform commercialization

Cham, Switzerland. Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics. Review completed on 24 Apr 2026.

2026 technical specializationCancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics
Core capabilities
4D-Comet Blood-Test TechnologyCE-IVD Cancer DiagnosticsHigh-Throughput Sample Processing
Governance

Swissmedic and EU IVDR for diagnostic oversight

CE-IVD certified 4D Lifetest applications, 23.3 million CHF financing, Public CEO disclosure

Editorial note

Cancer Early Detection, 4D-Comet Blood Test, and CE-IVD Oncology Diagnostics

Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record.

Editorial note

4D Lifetec is a Cham-based cancer-early-detection diagnostics startup with a named CEO since January 2023, CE-IVD applications across lung, breast, prostate, and colon, and a 23.3 million CHF financing round.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

4D-Comet Blood-Test Technology
CE-IVD Cancer Diagnostics
High-Throughput Sample Processing
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidence4D Lifetec company page naming Giancarlo Rizzoli as CEO since January 2023.Source origin: 4dlifetec.comOpen source
Supporting evidenceStartupticker coverage of 4D Lifetec's 23.3 million CHF financing.Source origin: startupticker.chOpen source
Physical-site evidenceStartupticker coverage placing 4D Lifetec in Cham, Zug.Source origin: startupticker.chOpen source
Infrastructure

Declared infrastructure

4D-Comet assay platform
High-throughput sample processing (up to 288 per run)
CE-IVD validation workflow
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
VERIFIED ACTIVE 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is 4D Lifetec AG located?
4D Lifetec AG operates from Cham, Zug, Switzerland, Cham, Switzerland.
Who runs 4D Lifetec AG?
4D Lifetec AG is led by Giancarlo Rizzoli, Chief Executive Officer. Verified 24 Apr 2026.
What certifications does 4D Lifetec AG hold?
4D Lifetec AG is documented under CE-IVD certified 4D Lifetest applications.
What does 4D Lifetec AG do?
Cham cancer-early-detection diagnostics startup with named CEO since January 2023, CE-IVD applications across four cancers, and 23.3 million CHF financing record. Core capabilities: 4D-Comet Blood-Test Technology, CE-IVD Cancer Diagnostics, High-Throughput Sample Processing.
Editorial context

Related technical briefs

Briefs that name Cham as a covered market or city.